Native mitral valve endocarditis caused by Staphylococcus lugdunensis in a 22-year-old woman [3]

Infection

Volumn 30, Issue 4, 2002, Pages 251-253

  Wachtler M ^a   Eichenlaub, D ^a   Strobel, E ^b   Koch, Ute ^b   Doering, W ^b   Overbeck, M ^c   Witte, W ^d  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Klinikum Schwabing   (Germany)

^c Clinic for Cardiac and Vessel Surgery   (Germany)

^d ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 GLOBULIN; BACITRACIN; BETA GLOBULIN; C REACTIVE PROTEIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN; ERYTHROMYCIN; FIBRINOGEN; FLUCLOXACILLIN; FURAZOLIDONE; FUSIDIC ACID; GENTAMICIN; HEMOGLOBIN; LYSOSTAPHIN; NOVOBIOCIN; OXACILLIN; OXYTETRACYCLINE; PENICILLIN G; PLASMA PROTEIN; PSEUDOMONIC ACID; QUINUPRISTIN; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ATOPY; BACTERIAL ENDOCARDITIS; CASE REPORT; CLINICAL CHEMISTRY; CLINICAL FEATURE; DEVICE; DISEASE COURSE; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMODYNAMIC MONITORING; HUMAN; HUMAN TISSUE; LETTER; MITRAL VALVE DISEASE; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PROTEIN ELECTROPHORESIS; RHINITIS; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS LUGDUNENSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; ANTI-BACTERIAL AGENTS; CARDIOVASCULAR SURGICAL PROCEDURES; ECHOCARDIOGRAPHY; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; MITRAL VALVE; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 0036392091     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-002-1116-3     Document Type: Letter

References (10)

1. Moreillon P: Endocarditis and endarteritis. In: Armstrong D, Cohen J (eds): Infectious diseases. Mosby, London 1999, pp 50.1-50.10.
2. Whitener C, Caputo GM, Weitekamp MR, Karchmer AW: Endocarditis due to coagulase-negative staphylococci: microbiologic, epidemiologic and clinical considerations. Infect Dis Clin N Am 1993; 7: 81-96.
3. Freney J, Brun Y, Bes M, Meugnier H, Grimont F, Grimont PAD, Nervi C, Fleurette J: Staphylococcus lugdunensis sp. nov. and Staphylococcus schieifferi sp. nov., two species from human clinical specimens. Int J Syst Bacteriol 1988; 38: 168-172.
4. Vandenesch F, Etienne J, Reverdy ME, Eykyn SJ: Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review. Clin Infect Dis 1993; 17: 871-876.
5. Burger SJ, Larocco MT, Wilansky S: Destructive native valve endocarditis caused by Staphylococcus lugdunensis. South Med J 1999; 92: 812-814.
6. Durack DT, Lukes AS, Bright DK: New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994; 96: 200-209.
7. Wooler GH, Nixon PGF, Grinshaw VA, Watson DA: Experience with the repair of the mitral valve in mitral valve incompetence. Thorax 1962; 17: 49.
8. Herchline TE, Ayers LW: Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection. J Clin Microbiol 1991; 29: 419-421.
9. Wassermann E, Lombard L, Walzl G: Staphylococcus lugdunensis endocarditis in a young, previously healthy female. Eur J Clin Microbiol Infect Dis 1999; 18: 289-291.
10. Moreillon P, Entenza JM, Francioli P: Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun 1995; 63: 4738-4743.